Patient and Scientific Review Board

This is why the main task of the Patient and Scientific Review Board is to evaluate requests for data based on the scientific rationale behind the request.

On this site, information about the composition of the Patient and Scientific Review Board, their working procedures, and their previous decisions are made available.

The Charter explains the procedures and decision making process of the Patient and Scientific Review Board. The Board consists of five members with different professional backgrounds and experience. Three seats are allocated to highly senior scientists, including one statistician, while the two remaining seats are allocated to representatives of patient associations. 

The CV for each board member can be found below.

Julie Block, President and CEO of National Eczema Association

Patient representative #2 - in process

Jennifer Rogers, Ph.D. Vice President for Statistical Research and Consultancy at PHASTAR

Thomas Bieber, M.D., Ph.D. Professor of Dermatology and Allergy

Marc Carrier, MD, MSc, FRCPC. Head of the Division of Hematology in the Department of Medicine at The Ottawa Hospital, Professor in the Faculty of Medicine, University of Ottawa

The next Board meeting will be planned upon receival of data request(s).

The number of data requests reviewed by the Patient and Scientific Review Board are listed below. For approved data requests the study ID, research title, and lay summary are provided.

Approved data access requests: 2

Declined data access requests: 0

Requested study: IN 0901 INT

Year: 2021

Research title: Risk of recurrent venous thromboembolism and bleeding in cancer patients: an individual patient data meta-analysis

Lay summary

Requested study: IN 0901 INT

Year: 2021

Research title: Efficacy and safety of anticoagulants for the treatment of acute venous thromboembolism (VTE) in patients with hematologic malignancies: a systematic review and individual patient level data meta-analysis 

Lay summary